Differential Sox10 genomic occupancy in myelinating glia

GLIA

Volumn 63, Issue 11, 2015, Pages 1897-1914

  Lopez Anido, Camila ^a,b   Sun, Guannan ^c   Koenning, Matthias ^d   Srinivasan, Rajini ^a   Hung, Holly A ^a,b   Emery, Ben ^d   Keles, Sunduz ^b   Svaren, John ^a,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chromatin; Enhancer; Myelin; Oligodendrocyte; Schwann; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; CLAUDIN 11; EARLY GROWTH RESPONSE FACTOR 2; HOMEODOMAIN PROTEIN; MYELIN; MYELIN PROTEIN; MYRF PROTEIN; NUCLEAR RECEPTOR NR2F1; NUCLEAR RECEPTOR NR2F2; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; SMALL INTERFERING RNA; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENOMICS; IN VIVO STUDY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN MOTIF; RAT; REGULATORY MECHANISM; SCHWANN CELL; SCIATIC NERVE; SEQUENCE ANALYSIS; SPINAL CORD;

EID: 84941172476     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22855     Document Type: Article

References (114)

1. Antonellis A, Dennis MY, Burzynski G, Huynh J, Maduro V, Hodonsky CJ, Khajavi M, Szigeti K, Mukkamala S, Bessling SL, Pavan WJ, McCallion AS, Lupski JR, Green ED; NISC Comparative Sequencing Program. 2010. A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo. PLoS One 5:e14346.
2. Antonellis A, Huynh JL, Lee-Lin SQ, Vinton RM, Renaud G, Loftus SK, Elliot G, Wolfsberg TG, Green ED, McCallion AS, Pavan WJ. 2008. Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish. PLoS Genet 4:e1000174.
3. Appel B. 2013. Nonmammalian Vertebrate Glia. In: Kettenman H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. pp 24-31.
4. Arvey A, Agius P, Noble WS, Leslie C. 2012. Sequence and chromatin determinants of cell-type-specific transcription factor binding. Genome Res 22:1723-34.
5. Azzedine H, Zavadakova P, Planté-Bordeneuve V, Vaz Pato M, Pinto N, Bartesaghi L, Zenker J, Poirot O, Bernard-Marissal N, Arnaud Gouttenoire E, Cartoni R, Title A, Venturini G, Médard JJ, Makowski E, Schöls L, Claeys KG, Stendel C, Roos A, Weis J, Dubourg O, Leal Loureiro J, Stevanin G, Said G, Amato A, Baraban J, LeGuern E, Senderek J, Rivolta C, Chrast R. 2013. PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease. Hum Mol Genet 22:4224-4232.
6. Blaise S, Kneib M, Rousseau A, Gambino F, Chenard MP, Messadeq N, Muckenstrum M, Alpy F, Tomasetto C, Humeau Y, Rio MC. 2012. In vivo evidence that TRAF4 is required for central nervous system myelin homeostasis. PLoS One 7:e30917.
7. Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M. 2001. Human connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-tooth disease, is directly regulated by the transcription factor sox10. Hum Mol Genet 10:2783-2795.
8. Bremer M, Fröb F, Kichko T, Reeh P, Tamm ER, Suter U, Wegner M. 2011. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 59:1022-1032.
9. Brewer MH, Ma KH, Beecham GW, Gopinath C, Baas F, Choi BO, Reilly MM, Shy ME, Züchner S, Svaren J, Antonellis A . 2014. Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2. Hum Mol Genet 23:5171-5187.
10. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M. 2001. The transcription factor sox10 is a key regulator of peripheral glial development. Genes Dev 15:66-78.
11. Bronstein JM, Kozak CA, Chen XN, Wu S, Danciger M, Korenberg JR, Farber DB. 1996. Chromosomal localization of murine and human oligodendrocyte-specific protein genes. Genomics 34:255-257.
12. Brosius Lutz A, Barres BA. 2014. Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev Cell 28:7-17.
13. Bujalka H, Koenning M, Jackson S, Perreau VM, Pope B, Hay CM, Mitew S, Hill AF, Lu QR, Wegner M, Srinivasan R, Svaren J, Willingham M, Barres BA, Emery B. 2013. MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol 11:e1001625.
14. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28:264-278.
15. Chen L, Loh PG, Song H. 2010. Structural and functional insights into the TEAD-YAP complex in the hippo signaling pathway. Protein Cell 1:1073-1083.
16. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:21931-21936.
17. Dawson MR, Polito A, Levine JM, Reynolds R. 2003. NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24:476-488.
18. Denarier E, Forghani R, Farhadi HF, Dib S, Dionne N, Friedman HC, Lepage P, Hudson TJ, Drouin R, Peterson A. 2005. Functional organization of a schwann cell enhancer. J Neurosci 25:11210-11217.
19. Doerflinger NH, Macklin WB, Popko B. 2003. Inducible site-specific recombination in myelinating cells. Genesis 35:63-72.
20. Dutta DJ, Zameer A, Mariani JN, Zhang J, Asp L, Huynh J, Mahase S, Laitman BM, Argaw AT, Mitiku N, Urbanski M, Melendez-Vasquez CV, Casaccia P, Hayot F, Bottinger EP, Brown CW, John GR. 2014. Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination. Development 141:2414-2428.
21. Emery B. 2013. Playing the field: Sox10 recruits different partners to drive central and peripheral myelination. PLoS Genet 9:e1003918
22. Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. 2009. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172-185.
23. Farhadi HF, Lepage P, Forghani R, Friedman HC, Orfali W, Jasmin L, Miller W, Hudson TJ, Peterson AC. 2003. A combinatorial network of evolutionarily conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes. J Neurosci 23:10214-10223.
24. Forrest MP, Hill MJ, Quantock AJ, Martin-Rendon E, Blake DJ. 2014. The emerging roles of tcf4 in disease and development. Trends Mol Med.
25. Fulton DL, Denarier E, Friedman HC, Wasserman WW, Peterson AC. 2011. Towards resolving the transcription factor network controlling myelin gene expression. Nucleic Acids Res 39:7974-7991.
26. Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM. 2013. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell 52:25-36.
27. Ghislain J, Charnay P. 2006. Control of myelination in schwann cells: A krox20 cis-regulatory element integrates oct6, brn2 and sox10 activities. EMBO Rep 7:52-58.
28. Ghislain J, Desmarquet-Trin-Dinh C, Jaegle M, Meijer D, Charnay P, Frain M. 2002. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of krox20 during schwann cell development. Development 129:155-166.
29. Gotoh L, Inoue K, Helman G, Mora S, Maski K, Soul JS, Bloom M, Evans SH, Goto Y, Caldovic L, Hobson GM, Vanderver A. 2014. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. Mol Genet Metab 111:393-398.
30. He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P. 2007. The transcription factor yin yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217-230.
31. He Y, Kim JY, Dupree J, Tewari A, Melendez-Vasquez C, Svaren J, Casaccia P. 2010. Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat Neurosci 13:1472-1480.
32. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576-589.
33. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-947.
34. Hornig J, Fröb F, Vogl MR, Hermans-Borgmeyer I, Tamm ER, Wegner M. 2013. The transcription factors sox10 and myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS Genet 9:e1003907
35. Houlden H, Girard M, Cockerell C, Ingram D, Wood NW, Goossens M, Walker RW, Reilly MM. 2004. Connexin 32 promoter p2 mutations: A mechanism of peripheral nerve dysfunction. Ann Neurol 56:730-734.
36. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
37. Hung HA, Sun G, Keles S, Svaren J. 2015. Dynamic Regulation of Schwann Cell Enhancers after Peripheral Nerve Injury. J Biol Chem 290:6937-6950.
38. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, Lupski JR. 2004. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36:361-369.
39. Inoue K, Shilo K, Boerkoel CF, Crowe C, Sawady J, Lupski JR, Agamanolis DP. 2002. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-hirschsprung disease: Phenotypes linked by sox10 mutation. Ann Neurol 52:836-842.
40. Jiang Q, Ho YY, Hao L, Nichols Berrios C, Chakravarti A. 2011. Copy number variants in candidate genes are genetic modifiers of hirschsprung disease. PLoS One 6:e21219
41. Jones EA, Brewer MH, Srinivasan R, Krueger C, Sun G, Charney KN, Keles S, Antonellis A, Svaren J. 2012. Distal enhancers upstream of the Charcot-Marie-tooth type 1A disease gene pmp22. Human Molecular Genetics 21:1581-1591.
42. Jones EA, Jang SW, Mager GM, Chang L-W, Srinivasan R, Gokey NG, Ward RM, Nagarajan R, Svaren J. 2007. Interactions of sox10 and egr2 in myelin gene regulation. Neuron Glia Biol 3:377-387.
43. Jung M, Krämer E, Grzenkowski M, Tang K, Blakemore W, Aguzzi A, Khazaie K, Chlichlia K, von Blankenfeld G, Kettenmann H. 1995. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 7:1245-1265.
44. Kamachi Y, Kondoh H. 2013. Sox proteins: Regulators of cell fate specification and differentiation. Development 140:4129-4144.
45. Kaplan T, Li XY, Sabo PJ, Thomas S, Stamatoyannopoulos JA, Biggin MD, Eisen MB. 2011. Quantitative models of the mechanisms that control genome-wide patterns of transcription factor binding during early drosophila development. PLoS Genet 7:e1001290
46. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, Harte RA, Heitner S, Hinrichs AS, Learned K, Lee BT, Li CH, Raney BJ, Rhead B, Rosenbloom KR, Sloan CA, Speir ML, Zweig AS, Haussler D, Kuhn RM, Kent WJ. 2014. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 42:D764-D770.
47. Kasprzyk A. 2011. BioMart: Driving a paradigm change in biological data management. Database (Oxford) 2011:bar049.
48. Kellerer S, Schreiner S, Stolt CC, Scholz S, Bösl MR, Wegner M. 2006. Replacement of the sox10 transcription factor by sox8 reveals incomplete functional equivalence. Development 133:2875-2886.
49. Kim HJ, Hong YB, Park JM, Choi YR, Kim YJ, Yoon BR, Koo H, Yoo JH, Kim SB, Park M, Chung KW, Choi BO. 2013. Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease. Orphanet J Rare Dis 8:104.
50. Kim YJ, Lim H, Li Z, Oh Y, Kovlyagina I, Choi IY, Dong X, Lee G. 2014. Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor. Cell Stem Cell 15:497-506.
51. King RH, Chandler D, Lopaticki S, Huang D, Blake J, Muddle JR, Kilpatrick T, Nourallah M, Miyata T, Okuda T, Carter KW, Hunter M, Angelicheva D, Morahan G, Kalaydjieva L. 2011. Ndrg1 in development and maintenance of the myelin sheath. Neurobiol Dis 42:368-3680.
52. Koenning M, Jackson S, Hay CM, Faux C, Kilpatrick TJ, Willingham M, Emery B. 2012. Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. J Neurosci 32:12528-12542.
53. Kuan PF, Chung D, Pan G, Thomson JA, Stewart R, Keles S. 2011. A statistical framework for the analysis of ChIP-Seq data. J Am Stat Assoc 106:891-903.
54. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18:237-250.
55. Kumada T, Yamanaka Y, Kitano A, Shibata M, Awaya T, Kato T, Okawa K, Abe T, Oshima N, Nakahata T, Heike T. 2010. Ttyh1, a Ca(2+)-binding protein localized to the endoplasmic reticulum, is required for early embryonic development. Dev Dyn 239:2233-2245.
56. Küspert M, Weider M, Müller J, Hermans-Borgmeyer I, Meijer D, Wegner M. 2012. Desert hedgehog links transcription factor sox10 to perineurial development. J Neurosci 32:5472-5480.
57. Lang J, Maeda Y, Bannerman P, Xu J, Horiuchi M, Pleasure D, Guo F. 2013. Adenomatous polyposis coli regulates oligodendroglial development. J Neurosci 33:3113-3130.
58. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25
59. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J. 2005a. Analysis of congenital hypomyelinating Egr2Lo/lo nerves identifies sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci U S A 102:2596-2601.
60. Le N, Nagarajan R, Wang JY, Svaren J, LaPash C, Araki T, Schmidt RE, Milbrandt J. 2005b. Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci 8:932-940.
61. LeBlanc SE, Jang SW, Ward RM, Wrabetz L, Svaren J. 2006. Direct regulation of myelin protein zero expression by the egr2 transactivator. J Biol Chem 281:5453-5460.
62. LeBlanc SE, Ward RM, Svaren J. 2007. Neuropathy-associated egr2 mutants disrupt cooperative activation of myelin protein zero by egr2 and sox10. Mol Cell Biol 27:3521-3529.
63. Li H, Lu Y, Smith HK, Richardson WD. 2007. Olig1 and sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes. J Neurosci 27:14375-14382.
64. Liang K, Keles S. 2012. Detecting differential binding of transcription factors with ChIP-seq. Bioinformatics 28:121-122.
65. Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M, Qiu M. 2007. Induction of oligodendrocyte differentiation by olig2 and sox10: Evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 302:683-693.
66. Meyer E, Kurian MA, Morgan NV, McNeill A, Pasha S, Tee L, Younis R, Norman A, van der Knaap MS, Wassmer E, Trembath RC, Brueton L, Maher ER. 2011. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease. Mol Genet Metab 104:637-643.
67. Mirny LA. 2010. Nucleosome-mediated cooperativity between transcription factors. Proc Natl Acad Sci U S A 107:22534-22539.
68. Mitew S, Hay CM, Peckham H, Xiao J, Koenning M, Emery B. 2014. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience 276:29-47.
69. Najm FJ, Lager AM, Zaremba A, Wyatt K, Caprariello AV, Factor DC, Karl RT, Maeda T, Miller RH, Tesar PJ. 2013. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol 31:426-433.
70. Nakatani H, Martin E, Hassani H, Clavairoly A, Maire CL, Viadieu A, Kerninon C, Delmasure A, Frah M, Weber M, Nakafuku M, Zalc B, Thomas JL, Guillemot F, Nait-Oumesmar B, Parras C. 2013. Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination. J Neurosci 33:9752-9768.
71. Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468:244-252.
72. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535-561.
73. Newbern J, Birchmeier C. 2010. Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin Cell Dev Biol 21:922-928.
74. Osaka H, Hamanoue H, Yamamoto R, Nezu A, Sasaki M, Saitsu H, Kurosawa K, Shimbo H, Matsumoto N, Inoue K. 2010. Disrupted sox10 regulation of gjc2 transcription causes Pelizaeus-Merzbacher-like disease. Ann Neurol 68:250-254.
75. Palazuelos J, Klingener M, Aguirre A. 2014. TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through smad3/4/FoxO1/sp1. J Neurosci 34:7917-7930.
76. Parras CM, Hunt C, Sugimori M, Nakafuku M, Rowitch D, Guillemot F. 2007. The proneural gene mash1 specifies an early population of telencephalic oligodendrocytes. J Neurosci 27:4233-4242.
77. Qi Y, Cai J, Wu Y, Wu R, Lee J, Fu H, Rao M, Sussel L, Rubenstein J, Qiu M. 2001. Control of oligodendrocyte differentiation by the nkx2.2 homeodomain transcription factor. Development 128:2723-2733.
78. Quednow BB, Brzózka MM, Rossner MJ. 2014. Transcription factor 4 (TCF4) and schizophrenia: Integrating the animal and the human perspective. Cell Mol Life Sci.
79. Quintes S, Goebbels S, Saher G, Schwab MH, Nave KA. 2010. Neuron-glia signaling and the protection of axon function by Schwann cells. J Peripher Nerv Syst 15:10-16.
80. Rada-Iglesias A, Bajpai R, Prescott S, Brugmann SA, Swigut T, Wysocka J. 2012. Epigenomic annotation of enhancers predicts transcriptional regulators of human neural crest. Cell Stem Cell 11:633-648.
81. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279-283.
82. Reiprich S, Kriesch J, Schreiner S, Wegner M. 2010. Activation of krox20 gene expression by sox10 in myelinating Schwann cells. J Neurochem 112:744-754.
83. Riccomagno MM, Hurtado A, Wang H, Macopson JG, Griner EM, Betz A, Brose N, Kazanietz MG, Kolodkin AL. 2012. The RacGAP β2-chimaerin selectively mediates axonal pruning in the hippocampus. Cell 149:1594-1606.
84. Scherer SS, Wrabetz L. 2008. Molecular mechanisms of inherited demyelinating neuropathies. Glia 56:1578-1589.
85. Schlierf B, Werner T, Glaser G, Wegner M. 2006. Expression of connexin47 in oligodendrocytes is regulated by the sox10 transcription factor. J Mol Biol 36:11-21.
86. Serrano I, McDonald PC, Lock F, Muller WJ, Dedhar S. 2013. Inactivation of the hippo tumour suppressor pathway by integrin-linked kinase. Nat Commun 4:2976
87. Srinivasan R, Sun G, Keles S, Jones EA, Jang SW, Krueger C, Moran JJ, Svaren J. 2012. Genome-wide analysis of egr2/sox10 binding in myelinating peripheral nerve. Nucleic Acids Res 40:6449-6460.
88. Stefflova K, Thybert D, Wilson MD, Streeter I, Aleksic J, Karagianni P, Brazma A, Adams DJ, Talianidis I, Marioni JC, Flicek P, Odom DT. 2013. Cooperativity and rapid evolution of cobound transcription factors in closely related mammals. Cell 154:530-540.
89. Stolt CC, Lommes P, Friedrich RP, Wegner M. 2004. Transcription factors sox8 and sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development 131:2349-2358.
90. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor sox10. Genes Dev 16:165-170.
91. Sugimori M, Nagao M, Bertrand N, Parras CM, Guillemot F, Nakafuku M. 2007. Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord. Development 134:1617-1629.
92. Sugimori M, Nagao M, Parras CM, Nakatani H, Lebel M, Guillemot F, Nakafuku M. 2008. Ascl1 is required for oligodendrocyte development in the spinal cord. Development 135:1271-1281.
93. Svaren J, Meijer D. 2008. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56:1541-1551.
94. Sweatt JD. 2013. Pitt-hopkins syndrome: Intellectual disability due to loss of TCF4-regulated gene transcription. Exp Mol Med 45:e21
95. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799.
96. Tuason MC, Rastikerdar A, Kuhlmann T, Goujet-Zalc C, Zalc B, Dib S, Friedman H, Peterson A. 2008. Separate proteolipid protein/dm20 enhancers serve different lineages and stages of development. J Neurosci 28:6895-6903.
97. Vigo T, Nobbio L, Hummelen PV, Abbruzzese M, Mancardi G, Verpoorten N, Verhoeven K, Sereda MW, Nave KA, Timmerman V, Schenone A. 2005. Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis. Mol Cell Neurosci 28:703-714.
98. Vogl MR, Reiprich S, Küspert M, Kosian T, Schrewe H, Nave KA, Wegner M. 2013. Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. J Neurosci 33:6679-6690.
99. Wahlbuhl M, Reiprich S, Vogl MR, Bösl MR, Wegner M. 2012. Transcription factor sox10 orchestrates activity of a neural crest-specific enhancer in the vicinity of its gene. Nucleic Acids Res 40:88-101.
100. Wang J, Pol SU, Haberman AK, Wang C, O'Bara MA, Sim FJ. 2014. Transcription factor induction of human oligodendrocyte progenitor fate and differentiation. Proc Natl Acad Sci U S A.
101. Wasseff SK, Scherer SS. 2011. Cx32 and cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte:oligodendrocyte gap junction coupling. Neurobiol Dis 42:506-513.
102. Weider M, Reiprich S, Wegner M. 2013. Sox appeal-Sox10 attracts epigenetic and transcriptional regulators in myelinating glia. Biol Chem 394:1583-1593.
103. Weng Q, Chen Y, Wang H, Xu X, Yang B, He Q, Shou W, Higashi Y, van den Berghe V, Seuntjens E, Kernie SG, Bukshpun P, Sherr EH, Huylebroeck D, Lu QR. 2012. Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 73:713-728.
104. Werner T, Hammer A, Wahlbuhl M, Bösl MR, Wegner M. 2007. Multiple conserved regulatory elements with overlapping functions determine sox10 expression in mouse embryogenesis. Nucleic Acids Res 35:6526-6538.
105. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307-319.
106. Wiernasz E, Kaliszewska A, Brutkowski W, Bednarczyk J, Gorniak M, Kaza B, Lukasiuk K. 2014. Ttyh1 protein is expressed in glia in vitro and shows elevated expression in activated astrocytes following status epilepticus. Neurochem Res 39:2516-2526.
107. Wissmüller S, Kosian T, Wolf M, Finzsch M, Wegner M. 2006. The high-mobility-group domain of sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res 34:1735-1744.
108. Yamaguchi H, Zhou C, Lin SC, Durand B, Tsai SY, Tsai MJ. 2004. The nuclear orphan receptor COUP-TFI is important for differentiation of oligodendrocytes. Dev Biol 266:238-251.
109. Yang N, Zuchero JB, Ahlenius H, Marro S, Ng YH, Vierbuchen T, Hawkins JS, Geissler R, Barres BA, Wernig M. 2013. Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol 31:434-439.
110. Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X, Liu L, Liu W, Wu LM, Mao M, Chan JR, Wu J, Lu QR. 2013. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152:248-261.
111. Yuelling LW, Waggener CT, Afshari FS, Lister JA, Fuss B. 2012. Autotaxin/enpp2 regulates oligodendrocyte differentiation in vivo in the developing zebrafish hindbrain. Glia 60:1605-1618.
112. Zalc B, Goujet D, Colman D. 2008. The origin of the myelination program in vertebrates. Curr Biol 18:R511-R512.
113. Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS, Green MR. 2010. ChIPpeakAnno: A bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11:237
114. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in schwann cell differentiation. Mol Cell Neurosci 8:129-145.